⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Continuous Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035
globenewswire.com
TMO
DHR
MRK
Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients
globenewswire.com
ADM
MRK
Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider
globenewswire.com
PFE
LLY
MRK
GILD
ABBV
BMY
AMGN
PBYI
GSK
TEVA
EXEL
Specialty Pharmaceuticals Market (2026-2031) - Rising Prevalence of Chronic and Rare Diseases Drives Growth
globenewswire.com
ABBV
AMGN
AZN
BIIB
BMRA
BMY
JNJ
MRK
NVS
PFE
REGN
SNY
TEVA
VRTX
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
globenewswire.com
PFE
NVS
AZN
SNY
LLY
JNJ
MRK
AMGN
BIIB
GILD
BMY
ABBV
XRAY
VTRS
TEVA
SUN
DS1025 Enters Clinical Development in Patients with Advanced Solid Tumors as Novel CD25 Directed ADC in Industry-Leading ADC Portfolio of Daiichi Sankyo
businesswire.com
AZN
MRK
Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
ASMB
IONS
BIIB
ALT
TEVA
ANVS
SUPN
ABBV
AVXL
MRK
KAR
VNDA
Strengthen Total AAV Potency Assurance with NGS Sequence Analysis, Upcoming Webinar Hosted by Xtalks
prnewswire.com
MRK
Ministry of Food and Drug Safety of Korea, Accelerates the Pace of Innovation for the Great Leap in Bio
prnewswire.com
MRK
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX